Paul Taubman, Founder, Chairman & CEO, emphasized "record revenues, record adjusted pretax income and record adjusted EPS" for 2025, attributing the strong performance to sustained investment in ...
Management reiterated guidance for 2025, expecting core revenue to be flat to a 10% decline compared to 2024, inclusive of SeQure DX revenue. SPL program-related revenue for 2025 is expected to be ...
In today's rapidly evolving economic landscape, businesses are navigating challenging shifts in the operating environment. From geopolitical tensions and the resultant supply chain disruptions to ...
Whether happening in public or private, biopharma M&A is fiercer than ever. Experts point to patent pressures, herd mentality ...
In this episode, Alan Condon, Editor-in-Chief at Becker’s Healthcare, highlights the latest financial trends in healthcare, including hospital system restructuring, leadership role reductions, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results